TRAM Snapshot of App at Pub for Oppostn

VAXZEVRIA

AstraZeneca UK Limited

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 90379679 FILING DATE 12/14/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY KHOURI, SANI PHILIPPE
L.O. ASSIGNED 110

PUB INFORMATION

RUN DATE 07/22/2021
PUB DATE 08/24/2021
STATUS 681-PUBLICATION/ISSUE REVIEW COMPLETE
STATUS DATE 07/21/2021
LITERAL MARK ELEMENT VAXZEVRIA

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E YES 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT VAXZEVRIA
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME AstraZeneca UK Limited
ADDRESS 1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, CB20AA
ENTITY 16-LTD LIAB CO
CITIZENSHIP United Kingdom

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations and substances, namely, vaccines

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

FOREIGN INFORMATION

PRIORITY CLAIMED SEC. 44(D) ON United Kingdom
APPLICATION NO. UK00003555632
APPLICATION FILING DATE 11/13/2020
FOREIGN REG NO. N/A
FOREIGN REG DATE N/A
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION N/A
FOREIGN RNWL EXPIRATION N/A
PRIORITY CLAIMED SEC. 44(D) ON United Kingdom
APPLICATION NO. 00003555632
APPLICATION FILING DATE 11/13/2020
FOREIGN REG NO. UK00003555632
FOREIGN REG DATE 03/26/2021
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 11/13/2030
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
07/21/2021 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED 012
07/21/2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 011
07/20/2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 010
07/20/2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 009
07/16/2021 ALIE A ASSIGNED TO LIE 008
06/21/2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
06/08/2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
06/08/2021 GNRT F NON-FINAL ACTION E-MAILED 005
06/08/2021 CNRT R NON-FINAL ACTION WRITTEN 004
06/07/2021 DOCK D ASSIGNED TO EXAMINER 003
02/21/2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
12/17/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Wm. Charles Saunders
CORRESPONDENCE ADDRESS Wm. Charles Saunders
Wm. Charles Saunders
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, A2C
WILMINGTON, DE, , , 19850-5437
DOMESTIC REPRESENTATIVE Wm. Charles Saunders

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed